Dyne Therapeutics Overview
Dyne Therapeutics Target Price
Where could DYN trade next? Consensus target price: $39.
Get informed when a big investor buys or sells
+ FollowShare Price
$15.72
Average Target Price
$39.00
148.1% upside
148.1% upside10 analysts in the last 4 months
High: $50 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-30 | Stifel NicolausPaul Matteis | $37 | 135.4% upside |  |
| 2026-09-30 | H.C. Wainwright | $32 | 103.6% upside | |
| 2026-09-30 | JefferiesAndrew Tsai | $50 | 218.1% upside | |
| 2026-09-29 | Piper SandlerEdward Tenthoff | $47 | 199% upside | |
| 2026-09-09 | Morgan Stanley | $36 | 129% upside | |
| 2026-09-09 | RBC Capital | $30 | 90.8% upside | |
| 2026-09-09 | Robert W. BairdBrian Skorney | $26 | 65.4% upside | |
| 2026-09-08 | Raymond JamesMichael Freeman | $37 | 135.4% upside | |
| 2026-08-17 | H.C. WainwrightAndrew Fein | $50 | 218.1% upside | |
| 2026-07-31 | Morgan Stanley | $45 | 186.3% upside | |
| 2026-05-15 | Evercore ISI | $33 | 109.9% upside | |
| 2026-05-13 | Bernstein | $24 | 52.7% upside | |
| 2026-03-02 | Chardan CapitalKeay Nakae | $38 | 141.7% upside | |
| 2026-03-02 | Morgan StanleyMichael E Ulz | $47 | 199% upside | |
| 2025-12-15 | Evercore ISIGavin Clark-Gartner | $36 | 129% upside | |
| 2025-12-11 | Stifel Nicolaus | $39 | 148.1% upside | |
| 2025-12-10 | Oppenheimer | $40 | 154.5% upside | |
| 2025-12-09 | Tudor PickeringWilliam Pickering | $23 | 46.3% upside | |
| 2025-12-09 | Bernstein | $23 | 46.3% upside | |
| 2025-12-08 | Morgan StanleyMichael E Ulz | $50 | 218.1% upside | |
| 2025-12-08 | Robert W. BairdBrian Skorney | $30 | 90.8% upside | |
| 2025-12-08 | H.C. WainwrightAndrew Fein | $60 | 281.7% upside | |
| 2025-12-08 | Raymond JamesMichael Freeman | $40 | 154.5% upside | |
| 2025-11-25 | Bernstein | $21 | 33.6% upside | |
| 2025-11-06 | Evercore ISIGavin Clark-Gartner | $38 | 141.7% upside | |
| 2025-10-10 | Oppenheimer | $13 |  17.3% downside | |
| 2025-08-25 | Raymond JamesStrong Buy | $35 | 122.6% upside | |
| 2025-06-02 | OppenheimerAndreas Argyrides | $34 | 116.3% upside | |
| 2025-02-28 | UBS | $48 | 205.3% upside | |
| 2025-02-28 | H.C. Wainwright | $46 | 192.6% upside | |
| 2024-08-14 | Morgan StanleyMichael Ulz | $52 | 230.8% upside | |
| 2024-08-13 | Piper SandlerEdward Tenthoff | $53 | 237.2% upside | |
| 2024-06-24 | JefferiesEun Yang | $42 | 167.2% upside | |
| 2024-06-17 | OppenheimerFrancois Brisebois | $55 | 249.9% upside | |
| 2024-05-21 | Chardan CapitalKeay Nakae | $42 | 167.2% upside | |
| 2024-05-20 | H.C. WainwrightAndrew Fein | $48 | 205.3% upside | |
| 2024-05-20 | Stifel NicolausPaul Matteis | $41 | 160.8% upside | |
| 2024-04-30 | Morgan StanleyMichael Ulz | $40 | 154.5% upside | |
| 2022-11-29 | J.P. Morgan | $18 | 14.5% upside | |
| 2022-09-06 | Piper SandlerEdward Tenthoff | $23 | 46.3% upside | |
| 2022-07-12 | Piper SandlerEdward Tenthoff | $17 | 8.1% upside | |